Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is a open Label, balanced, randomized, single dose, two-treatment, two-sequence,
two-period, crossover pivotal study. The purpose of this study is to assess the
bioequivalence between Test Product and the corresponding Reference Product under fasting
condition in healthy, adult human subjects.